Publications by authors named "William C Zamboni"

Invest New Drugs 2021 Feb 16. Epub 2021 Feb 16.

Department of Medical Oncology, Monash Health/Monash University, Melbourne, Australia.

Pharmaceutics 2021 Jan 17;13(1). Epub 2021 Jan 17.

UNC Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Sci Adv 2020 Jul 15;6(29):eaay9249. Epub 2020 Jul 15.

Carolina Center of Cancer Nanotechnology Excellence (C-CCNE), University of North Carolina, Chapel Hill, NC, USA.

Neurooncol Adv 2020 Jan-Dec;2(1):vdaa065. Epub 2020 Jun 3.

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

ACS Appl Mater Interfaces 2020 Apr 17;12(17):19345-19356. Epub 2020 Apr 17.

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 4211 Marsico Hall, 125 Mason Farm Road, Chapel Hill, North Carolina 27599, United States.

Antibodies (Basel) 2019 Jan 1;8(1). Epub 2019 Jan 1.

University of North Carolina (UNC), Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

J Control Release 2019 10 24;311-312:138-146. Epub 2019 Aug 24.

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; UNC/NCSU Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address:

Nanomedicine 2019 10 5;21:102076. Epub 2019 Aug 5.

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, United States; Department of Biomedical Engineering, University of North Carolina at Chapel Hill, United States; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, United States. Electronic address:

Am J Health Syst Pharm 2019 Apr;76(9):591-598

University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC.

Int J Gynecol Cancer 2019 01;29(1):147-152

University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Cancer Chemother Pharmacol 2019 01 16;83(1):61-70. Epub 2018 Oct 16.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Suite 1013, CB 7361, Chapel Hill, NC, 27599-7361, USA.

Adv Drug Deliv Rev 2018 Nov - Dec;136-137:82-96. Epub 2018 Sep 29.

Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, United States. Electronic address:

Methods Mol Biol 2018 ;1831:201-228

Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab, UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Cancer Chemother Pharmacol 2018 06 30;81(6):991-998. Epub 2018 Mar 30.

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.

Antibodies (Basel) 2018 Feb 7;7(1). Epub 2018 Feb 7.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Clin Breast Cancer 2018 08 28;18(4):289-297. Epub 2017 Oct 28.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

PLoS One 2017 5;12(10):e0186018. Epub 2017 Oct 5.

Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America.

Nanomedicine (Lond) 2017 Oct 27;12(20):2519-2532. Epub 2017 Sep 27.

Division of Pharmacotherapy & Experimental Therapeutics, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill, NC, USA.

J Oncol Pharm Pract 2017 10 9;23(7):558-560. Epub 2017 Aug 9.

1 Eshelman School of Pharmacy, University of North Carolina (UNC), Chapel Hill, NC, USA.

Nanomedicine (Lond) 2017 Aug 26;12(16):2021-2042. Epub 2017 Jul 26.

Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Neuro Oncol 2018 01;20(1):92-102

Lineberger Comprehensive Cancer Center.

Int J Pharm 2017 Jun 2;526(1-2):443-454. Epub 2017 May 2.

UNC Lineberger Comprehensive Cancer Center, Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address:

Nano Lett 2017 01 22;17(1):242-248. Epub 2016 Dec 22.

Department of Chemistry, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27515, United States.

Nanomedicine 2017 02 5;13(2):471-482. Epub 2016 Oct 5.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address:

Nanomedicine 2016 10 9;12(7):2007-2017. Epub 2016 Jun 9.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address:

Mol Pharm 2016 06 24;13(6):1996-2009. Epub 2016 May 24.

Nemucore Medical Innovations, Inc. , Worcester, Massachusetts 01608, United States.

Proc Natl Acad Sci U S A 2016 Feb 8;113(8):2200-5. Epub 2016 Feb 8.

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Division of Surgical Oncology, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599

Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016 09 5;8(5):642-53. Epub 2016 Feb 5.

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Cancer Chemother Pharmacol 2016 Mar 28;77(3):565-73. Epub 2016 Jan 28.

Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill-Eshelman School of Pharmacy, 120 Mason Farm Road, Suite 1013, CB 7361, Chapel Hill, NC, 27599-7361, USA.

J Pharm Biomed Anal 2016 Feb 28;119:122-9. Epub 2015 Nov 28.

Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, CB# 7569, Chapel Hill, NC 27599-7569, United States; UNC Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, CB# 7295, Chapel Hill, NC 27599-7295, United States; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, CB#7355, Chapel Hill, NC 27599-7355, United States; UNC Center for Pharmacogenomics and Individualized Therapy, 120 Mason Farm Road, CB# 7361, Chapel Hill, NC 27599, United States; Carolina Institute For NanoMedicine, University of North Carolina at Chapel Hill, 120 Mason Farm Road, 1079 Genetic Medicine Building, Chapel Hill, NC 27599-7264, United States. Electronic address: